NYSE - Delayed Quote USD

Enovis Corporation (ENOV)

55.51 -0.32 (-0.57%)
At close: April 22 at 4:00 PM EDT
Loading Chart for ENOV
DELL
  • Previous Close 55.83
  • Open 56.69
  • Bid 55.70 x 1000
  • Ask 89.55 x 800
  • Day's Range 55.33 - 56.89
  • 52 Week Range 43.04 - 66.14
  • Volume 903,121
  • Avg. Volume 437,601
  • Market Cap (intraday) 3.044B
  • Beta (5Y Monthly) 2.07
  • PE Ratio (TTM) --
  • EPS (TTM) -1.00
  • Earnings Date May 2, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 75.20

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

www.enovis.com

6,550

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ENOV

Performance Overview: ENOV

Trailing total returns as of 4/22/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ENOV
0.91%
S&P 500
5.05%

1-Year Return

ENOV
4.09%
S&P 500
21.22%

3-Year Return

ENOV
27.49%
S&P 500
20.06%

5-Year Return

ENOV
6.19%
S&P 500
72.48%

Compare To: ENOV

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ENOV

Valuation Measures

Annual
As of 4/22/2024
  • Market Cap

    3.04B

  • Enterprise Value

    3.54B

  • Trailing P/E

    --

  • Forward P/E

    20.96

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.77

  • Price/Book (mrq)

    0.89

  • Enterprise Value/Revenue

    2.08

  • Enterprise Value/EBITDA

    20.88

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -1.95%

  • Return on Assets (ttm)

    -0.10%

  • Return on Equity (ttm)

    -1.57%

  • Revenue (ttm)

    1.71B

  • Net Income Avi to Common (ttm)

    -54.37M

  • Diluted EPS (ttm)

    -1.00

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    36.19M

  • Total Debt/Equity (mrq)

    15.68%

  • Levered Free Cash Flow (ttm)

    44.11M

Research Analysis: ENOV

Analyst Price Targets

65.00
75.20 Average
55.51 Current
82.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: ENOV

Fair Value

55.51 Current
 

Dividend Score

0 Low
ENOV
Sector Avg.
100 High
 

Hiring Score

0 Low
ENOV
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
ENOV
Sector Avg.
100 High
 

Research Reports: ENOV

  • Analyst Report: Enovis Corp

    Enovis provides med-tech products and services under a range of brand names, including DJO Surgical, Mathys, and Motion MD/Motion IQ. The company employs approximately 6,500 people. The shares are a component of the S&P 400 MidCap Index.

    Rating
    Price Target
     
  • Market Update: ENOV

    Stocks were slightly down on Monday morning ahead of the holiday shortened week. This week brings new data on inflation, GDP, housing, durable goods, consumer confidence, personal spending, and personal income. In other news, Boeing (BA) CEO Calhoun announced his resignation without naming a successor. Apple (AAPL), Meta Platforms (META) and Alphabet (GOOGL) are being investigated by the EU for anticompetitive behavior. The S&P 500 fell 0.2%, the Dow was down 0.3% and the Nasdaq lost 0.1%. Crude oil traded near $82 per barrel and gold was up $16 to $2176 per ounce.

     
  • Analyst Report: Enovis Corp

    Enovis provides med-tech products and services under a range of brand names, including DJO Surgical, Mathys, and Motion MD/Motion IQ. The company employs approximately 7,000 people. The shares are a component of the S&P 400 MidCap Index.

    Rating
    Price Target
     
  • Market Update: ENOV

    Stocks were mixed on Monday morning. The DJIA is under pressure following another issue with Boeing's flagship aircraft, while the Nasdaq is heading higher. On the economic front, according to the December Survey of Consumer Expectations, median inflation expectations for the one-year-ahead hit the lowest level recorded since January 2021. Median inflation expectations declined for all timeframes, falling to 3.0% from 3.4% at one year, to 2.6% from 3.0% at three years, and to 2.5% from 2.7% at five years. Oil prices are down 4% after Saudi Arabia cut its official price for its Arab light crude to the lowest level in 27 months. The Dow fell 0.2%, while the S&P 500 is up 0.5%, and the Nasdaq gained 1.2%. Crude oil fell to $71 per barrel, while gold traded near $2040 per ounce.

     

People Also Watch